The Cigna Group with ticker code (CI) have now 24 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $420.00 and $349.00 suggesting an average analyst share price target price of $392.19. (at the time of writing). Now with the previous closing price of $329.91 and the analysts are correct then we can expect a percentage increase in value of 18.9%. It’s also worth noting that there is a 50 day moving average of $337.66 and the 200 moving average now moves to $321.38. The company has a market cap of 94.76B. The stock price is currently at: $333.56 USD
The potential market cap would be $112,643,583,696 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 27.41, revenue per share of $700.13 and a 3.08% return on assets.
The Cigna Group is a global health services company. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. The Company offers a differentiated set of pharmacy, medical, behavioral, dental and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes a range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions, which are provided to health plans, employers, government organizations and health care providers. Cigna Healthcare includes the United States Commercial, United States Government, and International Health operating segments, which provide medical and coordinated solutions to clients and customers.
